Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 44 Glioma 16 Melanoma 11 Central Nervous System Neoplasms 11 Astrocytoma 11 Brain Neoplasms 10 Oligodendroglioma 7 Gliosarcoma 5 Small Cell Lung Carcinoma 4 Recurrence 3 Lymphoma 3 Leiomyosarcoma 3 Sarcoma 2 Neoplasms, Neuroepithelial 2 Neoplasms 2 Neoplasm Metastasis 2 Ependymoma 2 Diffuse Intrinsic Pontine Glioma 2 Breast Neoplasms 2 Uveal Melanoma 1 Seizures 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrent Extensive Stage Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pituitary Neoplasms 1

Interventions

Surgical Procedures, Operative 3 Mammography 2 Liquid Biopsy 2 Interviews as Topic 2 Diagnostic Tests, Routine 2 Colonoscopy 2 weifuchun 1 Vitamins 1 Urination 1 Tranexamic Acid 1 Tomography, X-Ray Computed 1 Th1-Th2 Balance 1 Temozolomide 1 Surveys and Questionnaires 1 RNA, Long Noncoding 1 Positron Emission Tomography Computed Tomography 1 Occult Blood 1 Needles 1 MicroRNAs 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Lymph Node Excision 1 In Situ Hybridization 1 Hematologic Tests 1 HIV Testing 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Diffusion 1 Dermoscopy 1 Cystoscopy 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Disease × Temozolomide × Clear all

NCT00660283 2010-01-20

KARE003

Kentuckiana Cancer Institute

Phase 2 Unknown

Disease, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡